BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19716157)

  • 1. SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract.
    Long KB; Hornick JL
    Hum Pathol; 2009 Dec; 40(12):1768-73. PubMed ID: 19716157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping.
    DiMaio MA; Kwok S; Montgomery KD; Lowe AW; Pai RK
    Hum Pathol; 2012 Nov; 43(11):1799-807. PubMed ID: 22748473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa.
    Barros R; Pereira D; Callé C; Camilo V; Cunha AI; David L; Almeida R; Dias-Pereira A; Chaves P
    Dis Markers; 2016; 2016():1532791. PubMed ID: 27766003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
    Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
    Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
    Sholl LM; Long KB; Hornick JL
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):55-61. PubMed ID: 19661786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
    Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
    Werling RW; Yaziji H; Bacchi CE; Gown AM
    Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
    Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
    PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
    Owens SR; Greenson JK
    Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut.
    Bakhshwin AM; Gordon IO; Brown KB; Liu X; Allende DS
    Int J Surg Pathol; 2020 Dec; 28(8):835-843. PubMed ID: 32466705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
    Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
    Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Immunohistochemical Study of Anal Canal Epithelium in Humans and Swine, Focusing on the Anal Transitional Zone Epithelium and the Anal Glands.
    Muranaka F; Nakajima T; Iwaya M; Ishii K; Higuchi K; Ogiwara N; Miyagawa S; Ota H
    Anat Rec (Hoboken); 2018 May; 301(5):796-805. PubMed ID: 29232767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D
    Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
    Kermanshahi TR; Jayachandran P; Chang DT; Pai R
    Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
    Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
    Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.
    Ishida H; Kasajima A; Kamei T; Miura T; Oka N; Yazdani S; Ozawa Y; Fujishima F; Sakurada A; Nakamura Y; Tanaka Y; Kurosumi M; Ishikawa Y; Okada Y; Ohuchi N; Sasano H
    Mod Pathol; 2017 May; 30(5):660-671. PubMed ID: 28106103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
    Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
    Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
    Kaufmann O; Fietze E; Mengs J; Dietel M
    Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.